A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread

NCT03166631 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

62

Enrollment

INDUSTRY

Sponsor class

Stopped Not due to safety reasons.

Conditions

Neoplasms
Neoplasm Metastasis
Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: BI 891065
DRUG: BI 754091

Sponsor

Boehringer Ingelheim